Erschienen in:
24.02.2020 | Concise Research Report
Off-Label Coverage of High-Cost Drugs by Independent Charity Patient Assistance Programs
verfasst von:
So-Yeon Kang, MPH, MBA, Mariana P. Socal, MD, PhD, Ge Bai, PhD, CPA, Gerard F. Anderson, PhD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 2/2021
Einloggen, um Zugang zu erhalten
Excerpt
Independent charity patient assistance programs are funded by pharmaceutical companies to help eligible patients cover their out-of-pocket costs for prescription drugs.
1 Pharmaceutical companies are prohibited from advertising or distributing information about off-label uses of their products but commonly suggest off-label uses in their direct-to-consumer advertisements for certain drugs.
2, 3 Independent charity patient assistance programs had been prohibited from offering financial assistance for off-label uses until 2014,
4 when the US Department of Health and Human Services relaxed the guidelines to allow these programs to cover less expensive drugs for off-label uses.
5 The extent to which independent charity patient assistance programs have covered off-label uses of prescription drugs and the types of these covered drugs have not been examined. …